Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-02-16 Major Shareholding Noti…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera S.p.A.: Azionisti rilevanti
Major Shareholding Notification Classification · 1% confidence The document is a formal communication titled "Azionisti rilevanti" (Relevant Shareholders) from Bioera S.p.A., dated February 16, 2021. It explicitly states that shareholder Negma Group Limited has crossed the 5% voting capital threshold and provides an updated breakdown of the company's shareholding structure. This content directly relates to notifications about changes in significant share ownership, which corresponds to the Major Shareholding Notification category.
2021-02-16 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Capital/Financing Update Classification · 1% confidence The document is an official communication from Bioera S.p.A., identified by the header 'Informazione Regolamentata' (Regulated Information) and a specific filing ID (142394). The subject ('Oggetto') is 'Bioera S.p.A. - Richiesta di conversione Warrant A' (Request for conversion of Warrant A). The content details the receipt of a request from Negma Group Limited to convert 1,050,000 Warrant A into new ordinary shares and new Warrant B. This action directly relates to changes in the company's capital structure (issuance of new shares and warrants) resulting from a financing/investment agreement. This fits best under 'Capital/Financing Update' (CAP), as it describes the execution of a capital-related instrument (warrants conversion leading to new share issuance). It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV). Since it details the mechanics of a capital change, CAP is the most precise fit.
2021-02-10 Italian
Assemblea Straordinaria degli Azionisti 24-25-26 febbraio 2021 - Parere Società di Revisione
Audit Report / Information Classification · 1% confidence The document is titled "Relazione della società di revisione ai sensi dell'art. 2441, quinto e sesto comma, del codice civile, e dell'art. 158, primo comma, D. Lgs. 58/98" (Auditor's Report pursuant to Article 2441, fifth and sixth paragraphs, of the Civil Code, and Article 158, first paragraph, Legislative Decree 58/98). It explicitly discusses the proposal for a capital increase with exclusion of pre-emptive rights, referencing Italian corporate law (Codice Civile, TUF, Regolamento Consob) and the need for the auditor to express an opinion on the fairness of the issuance price criteria proposed by the Board of Directors. This structure—an auditor's report specifically reviewing a proposed capital increase/financing operation—is highly indicative of a document related to capital structure changes and financing activities, often accompanying such proposals. Since the core subject is the review of a proposed capital increase (a financing activity), the most appropriate classification is Capital/Financing Update (CAP), as it directly relates to the mechanics and justification of raising capital, even though it is an auditor's review of that proposal. It is not a general Audit Report (AR) as it is tied to a specific corporate action, nor is it a standard Annual Report (10-K) or Interim Report (IR). Q1 2021
2021-02-03 Italian
Assemblea Straordinaria degli Azionisti 24-25-26 febbraio 2021 - Relazione illustrativa Amministratori
AGM Information Classification · 1% confidence The document is titled "Relazione illustrativa degli Amministratori sulle proposte concernenti le materie poste all'Ordine del Giorno" (Explanatory report of the Directors on the proposals concerning the matters on the Agenda) for an "Assemblea Straordinaria" (Extraordinary Shareholders' Meeting) scheduled for February 24-26, 2021. It explicitly discusses proposals to modify a previous resolution regarding a capital increase linked to the exercise of warrants (Warrant A and B) and the resulting necessary amendments to the company's bylaws (Article 6). This document serves as the explanatory report provided to shareholders ahead of a general meeting to inform their vote on specific corporate actions, which aligns perfectly with the purpose of a Proxy Solicitation & Information Statement (PSI) or potentially an AGM-related document, although PSI is more specific for soliciting votes based on explanatory reports for meetings. Given the content focuses heavily on explaining proposed resolutions for a shareholders' meeting (including modifications to capital structure and warrants) and refers to the 'Ordine del Giorno' (Agenda), it is best classified as Proxy Solicitation & Information Statement (PSI), as it is the detailed material sent to shareholders to inform their vote on specific items. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Call Transcript (CT). While it relates to an assembly, it is the explanatory report, not the final voting results (DVA) or the AGM presentation itself (AGM-R).
2021-02-03 Italian
Bioera S.p.A. - Deposito documentazione Assemblea Straordinaria degli Azionisti
Report Publication Announcement Classification · 1% confidence The document is an official regulatory announcement (Informazione Regolamentata n. 0771-9-2021) dated February 3, 2021. The subject ('Oggetto') is the 'Deposito documentazione Assemblea Straordinaria degli Azionisti' (Filing of documentation for the Extraordinary Shareholders' Meeting). The text explicitly states that several documents (illustrative report, auditor's opinion, proxy forms) related to the upcoming shareholders' meeting have been published today and are available for consultation. Since this document is an announcement *about* the availability of materials for a shareholder meeting, and not the meeting materials themselves (like AGM-R or DEF 14A), it fits the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific context of announcing documentation for a shareholder meeting, RPA is a strong candidate, but since the core purpose is regulatory disclosure about meeting documents, and it is short and points to attachments/availability, RPA or RNS applies. The presence of specific documentation related to a shareholder meeting (which often involves voting/proxies) suggests a strong link to AGM/Proxy materials. However, the document itself is the *announcement* of the filing of these materials. Since the content is an announcement stating that documents for an Extraordinary Shareholders' Meeting have been published, and it is very short (4525 chars), it aligns best with the 'Report Publication Announcement' (RPA) category, as it announces the publication of other required documents. If the content were the actual proxy statement, it would be PSI, or if it were the results, DVA. As it is the announcement of the filing of preparatory documents for the meeting, RPA is the most precise fit among the options for an announcement document.
2021-02-03 Italian
Bioera S.p.A. - Informativa al mercato ai sensi dell’art. 114, comma 5, D.lgs. n. 58/98 (“TUF”) - periodo di riferimento: 31.12.2020
Management Reports Classification · 1% confidence The document is an official communication from Bioera S.p.A. dated January 29, 2021, titled "Informativa al mercato ai sensi dell'art. 114, comma 5, D.lgs. n. 58/98 ("TUF")" concerning the reference period ending 31.12.2020. This specific Italian regulation (TUF Article 114, paragraph 5) mandates the disclosure of key financial data, specifically Net Financial Position (Posizione Finanziaria Netta), for periods shorter than the annual report, usually quarterly or semi-annually, when requested by CONSOB or periodically. Since this report covers the period up to 31.12.2020 and provides detailed financial position data, it fits the definition of a comprehensive financial report for a period shorter than a year, which corresponds to the Interim / Quarterly Report (IR) category. It is not a full Annual Report (10-K), an Earnings Release (ER, which is usually just highlights), or a mere announcement of a report (RPA/RNS), as it contains the actual required financial data tables.
2021-01-29 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.